HomeCompareTBLMF vs ABBV

TBLMF vs ABBV: Dividend Comparison 2026

TBLMF yields 13.61% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBLMF wins by $3599876.29M in total portfolio value
10 years
TBLMF
TBLMF
● Live price
13.61%
Share price
$20.88
Annual div
$2.84
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3599876.40M
Annual income
$3,549,766,669,631.37
Full TBLMF calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — TBLMF vs ABBV

📍 TBLMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBLMFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBLMF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBLMF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBLMF
Annual income on $10K today (after 15% tax)
$1,156.74/yr
After 10yr DRIP, annual income (after tax)
$3,017,301,669,186.66/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, TBLMF beats the other by $3,017,301,648,130.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBLMF + ABBV for your $10,000?

TBLMF: 50%ABBV: 50%
100% ABBV50/50100% TBLMF
Portfolio after 10yr
$1799938.25M
Annual income
$1,774,883,347,201.56/yr
Blended yield
98.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

TBLMF
No analyst data
Altman Z
8.4
Piotroski
6/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBLMF buys
0
ABBV buys
0
No recent congressional trades found for TBLMF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBLMFABBV
Forward yield13.61%3.06%
Annual dividend / share$2.84$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%40.6%
Portfolio after 10y$3599876.40M$102.3K
Annual income after 10y$3,549,766,669,631.37$24,771.77
Total dividends collected$3596515.63M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TBLMF vs ABBV ($10,000, DRIP)

YearTBLMF PortfolioTBLMF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$13,422$2,721.73$11,550$430.00+$1.9KTBLMF
2$21,189$6,828.11$13,472$627.96+$7.7KTBLMF
3$42,822$20,149.11$15,906$926.08+$26.9KTBLMF
4$121,930$76,111.19$19,071$1,382.55+$102.9KTBLMF
5$535,547$405,081.69$23,302$2,095.81+$512.2KTBLMF
6$3,898,670$3,325,634.33$29,150$3,237.93+$3.87MTBLMF
7$49,423,743$45,252,166.17$37,536$5,121.41+$49.39MTBLMF
8$1,125,154,894$1,072,271,488.72$50,079$8,338.38+$1125.10MTBLMF
9$46,831,519,082$45,627,603,346.19$69,753$14,065.80+$46831.45MTBLMF
10$3,599,876,395,050$3,549,766,669,631.37$102,337$24,771.77+$3599876.29MTBLMF

TBLMF vs ABBV: Complete Analysis 2026

TBLMFStock

Tiger Brands Limited engages in the manufacture, marketing, and distribution of consumer goods primarily in South Africa. The company offers baby care products under the Purity brand; bakeries under the Albany and Tinkies brands; and culinary fruit veg products under the Crosse & Blackwell, Benny, All Gold, Spray and Cook, Ice Cap, KOO, Colman's, Black Cat, Mrs H.S. Ball's Chutney, and Hugo's brands. It also provides home care products under the Airoma, Bio Classic, Bio Crystal, Doom, Jeyes, and Peaceful Sleep brands; milling products under the Golden Cloud and Ace brands; rice pasta under the Fatti's and Moni's, Cresta, Tastic, and Aunt Caroline brands; and superfoods under the Ace, Jungle, King Korn, and Morvite brands. In addition, the company provides personal care products under the Dolly Varden, Kair, gill, Lemon Lite, No Hair, Perfect Touch, Protein Feed, Status, and Ingram's brands; and snacks, treats, and beverages under the Beacon, Maynards, Hall's, Sparkles, All Sorts, Oros, Jelly Tots, fizzer, Fizz Pop, Smoothies, Rose's, and Energade brands. Further, it provides out of home solutions and product offerings in various pack formats to franchised restaurant groups, hotel groups, catering groups, airlines, institutions, independent restaurants and coffee shops, independent hotels, game reserves, lodges, and bed and breakfast establishments; and product solutions for the establishment cleaning, pest control, and room air refreshing. The company also exports its products to approximately 25 countries in Africa. Tiger Brands Limited was founded in 1920 and is headquartered in Bryanston, South Africa.

Full TBLMF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this TBLMF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBLMF vs SCHDTBLMF vs JEPITBLMF vs OTBLMF vs KOTBLMF vs MAINTBLMF vs JNJTBLMF vs MRKTBLMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.